Yongmei Yan
West Weiyang Road
Xianyang, 712000, China
Xianyang, 712000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Comparative efficacy and safety of botanical drugs for mild cognitive impairment: a systematic review and network meta-analysis.
Journal: Frontiers in pharmacology
Published: July 03, 2025
Organoids and Organoids-on-Chip in Traditional Chinese Medicine Research: Applications, Advantages, and Future Prospects.
Journal: Cell biology international
Published: June 02, 2025
Safety of edaravone in real-world use: analysis based on FDA adverse event reporting system.
Journal: Expert opinion on drug safety
Published: February 21, 2025
The clinical efficacy of auricular acupuncture in the treatment of frequent episodic tension-type headache: a single-blind randomized controlled trial.
Journal: BMC complementary medicine and therapies
Published: January 19, 2025
Exploring the bidirectional relationship between depressive disorder and dyslipidemia: a systematic review and meta-analysis.
Journal: Frontiers in psychiatry
Published: September 20, 2024
Dementia and metabolic syndrome: a bibliometric analysis.
Journal: Frontiers in aging neuroscience
Published: March 13, 2024
Flaws in the meta-analysis of comparison between different types of exercise training in patients with type 2 diabetes mellitus: A letter to the editor.
Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD
Published: March 29, 2022
Efficacy and Safety of Xiaoyao Recipe in the Treatment of Poststroke Depression: A Systematic Review and Meta-Analysis.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: October 14, 2021
Xingnao Jieyu Decoction Reduces Neuroinflammation through the NF-κB Pathway to Improve Poststroke Depression.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: July 06, 2021
Antidepressant effect of Xingnao Jieyu decoction mediated by alleviating neuroinflammation in a rat model of post-stroke depression.
Journal: Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan
Published: March 19, 2020
Xingnao Jieyu Decoction Ameliorates Poststroke Depression through the BDNF/ERK/CREB Pathway in Rats.
Xingnao Jieyu Decoction Ameliorates Poststroke Depression through the BDNF/ERK/CREB Pathway in Rats.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: July 27, 2018
Schizandrin A protects against cerebral ischemia-reperfusion injury by suppressing inflammation and oxidative stress and regulating the AMPK/Nrf2 pathway regulation.
Journal: American journal of translational research
Published: June 29, 2018
Last Updated: 09/26/2026